10 Results for "

caveolae

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "caveolae" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-D3025
Synonyms: HSA-FITC
Target:  

Fluorescent Dye

Research Areas:  

Others

Human Serum Albumin-FITC (HSA-FITC) is a green fluorescent probe prepared by covalent conjugation of FITC with human serum albumin (HSA), with excitation/emission wavelengths of 488/505-550 nm. Human Serum Albumin-FITC (HSA-FITC) can be used to track nanotube conjugates taken up via caveolae-mediated endocytosis initiated by Gp60 receptor binding, and can also non-covalently adsorb to oxidized multi-walled carbon nanotubes. Human Serum Albumin-FITC (HSA-FITC) is widely applied in macrophage imaging, scavenger receptor targeting, and hepatoma cell imaging .
loading...
    loading...
Cat. No.: HY-171306
Target:  

Liposome

Research Areas:  

Others

MK16 is a lipid material that can be used to construct blood-brain barrier penetrable lipid nanoparticles for mRNA delivery. MK16 facilitates blood-brain barrier crossing via γ-secretase-mediated and caveolae-mediated transcytosis. MK16 can be used for drug delivery research .
loading...
    loading...
Cat. No.: HY-171905
CAS No.: 3069417-18-8
Target:  

Liposome

Research Areas:  

Others

N-Sterol is a sterol lipid that has been used to generate lipid nanoparticles (LNPs) for delivery of mRNA in vitro and in vivo. N-Sterol LNPs are taken up in J774A.1 macrophages in a lipid composition-dependent manner via clathrin caveolae, caveolin-mediated endocytosis, micropinocytosis, or phagocytosis at different frequencies .
loading...
    loading...
Cat. No.: HY-164290
CAS No.: 1367579-04-1
Target:  

Dynamin

Research Areas:  

Infection Neurological Disease

Rhodady C10 (Compound C10) is a dynamin I GTPase inhibitor. Rhodady C10 blocks receptor-mediated endocytosis (IC50: 7 μM). Dynamin is involved in clathrin-independent endocytosis, phagocytosis, and caveolae internalization .
loading...
    loading...
Cat. No.: HY-P790063
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CAV1; Caveolin; Prev. CAV; BSCL3; Caveolin 1, caveolae Protein, 22kDa; LCCNS; Caveolin-1; VIP21; Caveolin 1, caveolae Protein, 22kD; CGL3; Cell Growth-Inhibiting Protein 32; PPH3; Alternative Protein CAV1; Caveolin 1; MSTP085
Species:  
Human
Source:  
E. coli Cell-free
loading...
    loading...
Cat. No.: HY-P11741
Research Areas:  

Neurological Disease

BV2 is a delivery peptide that binds to BVES, with a Ka of 2.03 μM for the BVES target. BV2 specifically binds to the extracellular domain of BVES, achieving muscle homing and cellular internalization via caveolae-mediated endocytosis. When BV2 is modified on the surface of exosomes by PMO, it enhances dystrophin restoration in the peripheral muscles and myocardium of dystrophin-deficient mice. BV2 is applicable to research related to Duchenne muscular dystrophy and muscle atrophy .
loading...
    loading...
Cat. No.: HY-P82642
Synonyms: CAV2; caveolae protein 20 Kd; Caveolin 2; Caveolin 2 isoform a and b; Caveolin-2

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, FC

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P11797
Research Areas:  

Cardiovascular Disease

EP9 is a peptide targeting CD63. EP9 binds specifically to the extracellular region of CD63, including a groove in the large extracellular loop (EC2) or the extracellular end of CD63’s central cavity, triggering endocytosis of decorated nanoemulsions/liposomes into cells. EP9 promotes cellular uptake of decorated nanoemulsions/liposomes into activated cardiac fibroblasts and epicardial stromal cells via caveolae and/or clathrin-coated pits. EP9 can be used for the research of myocardial infarction, cardiac fibrosis .
loading...
    loading...
Cat. No.: HY-P82642A
Synonyms: CAV2; caveolae protein 20 Kd; Caveolin 2; Caveolin 2 isoform a and b; Caveolin-2

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, FC

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-188196
Research Areas:  

Neurological Disease

PVtCD-cTP-AlkF-2 is a ROS-responsive DAPK1 BmTAC activator with blood-brain barrier permeability. PVtCD-cTP-AlkF-2 is equipped with a VHL E3 ubiquitin ligase ligand modified with a ROS-responsive phenylboronic acid caging group, and undergoes uncaging activation only in a high-ROS microenvironment. PVtCD-cTP-AlkF-2 can selectively recognize and degrade dephosphorylated activated DAPK1. PVtCD-cTP-AlkF-2 exerts its activator function through caveolae-mediated transcytosis. PVtCD-cTP-AlkF-2 reduces APP and Tau phosphorylation, decreases Aβ oligomer deposition, and improves cognitive function in aged APP/PS1 mice. PVtCD-cTP-AlkF-2 can be used for research on Alzheimer's disease .
loading...
    loading...